2 Union Square, Union City, CA 94587
contact@NeoBiotechnologies.com
510-376-5603

Home >> Antibodies >> Immuno Oncology

Immuno Oncology

The following are the Immuno Oncology antibodies available from NeoBiotechnologies:


Refined By Reset
Clonality
Species Reactivity
Research Areas & Tissues
Known Applications
Found all antibodies, displaying 1 to 5

AKT1 (Prognostic Marker for Neuroendocrine Tumors)

Mouse Monoclonal Antibody  [Clone AKT1/2491]
Ig Isotype:
IgG2b, kappa
Known Applications:
Immunohistochemistry
Species:
Human.
Cellular Localization:
Nuclear, Cytoplasmic and Cell Surface
207-MSM1-P

B7-H4 (Immuno-Inhibitory Protein)

Recombinant Rabbit Monoclonal Antibody  [Clone B7H4/2652R]
Ig Isotype:
Rabbit / IgG
Known Applications:
ELISA, Flow Cytometry, Immunofluorescence, Immunohistochemistry
Species:
Human.
Cellular Localization:
Cell Surface & Cytoplasmic
79679-RBM2-P

Beta-2 Microglobulin (Renal Failure & Tumor Marker)

Mouse Monoclonal Antibody  [Clone 246-E9.E7; same as HLA.ABC.m2]
Ig Isotype:
IgG2a, kappa
Known Applications:
Flow Cytometry, Immunofluorescence
Species:
Human. Does not react with Non-Human primates.
Cellular Localization:
Cell Surface and Extracellular (Secreted)
567-MSM1-P

Beta-2 Microglobulin (Renal Failure & Tumor Marker)

Mouse Monoclonal Antibody  [Clone B2M/1118]
Ig Isotype:
IgG1, kappa
Known Applications:
Immunohistochemistry
Species:
Human. Non-Human primates.
Cellular Localization:
Cell Surface and Extracellular (Secreted)
567-MSM2-P

Beta-2 Microglobulin (Renal Failure & Tumor Marker)

Mouse Monoclonal Antibody  [Clone BBM.1]
Ig Isotype:
IgG2b, kappa
Known Applications:
Flow Cytometry, Western Blot, Immunofluorescence, Immunohistochemistry
Species:
Human. Non-Human primates.
Cellular Localization:
Cell Surface and Extracellular (Secreted)
567-MSM3-P
Contact Information
2 Union Square, Union City, CA 94587
contact@NeoBiotechnologies.com
510-376-5603
Privacy Policy  |  Terms of service
footer logo
© 2015 by NeoBiotechnologies.
www.NeoBiotechnologies.com
All rights reserved.
  • facebook
  • twitter
  • google plus
  • linkedIn